Net sales reached KSEK 3,008 in Q2 2024, with a net loss of KSEK -3,087 as Biofrigas nears its first commercial plant delivery and completes a major rights issue. Market interest and quotation volume are rising, supporting a positive outlook.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.